GeneMatrix Inc (109820) — Financial Flexibility Index
GeneMatrix Inc (109820) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of ₩523.83 Million (operating CF ₩500.19 Million minus capex ₩23.65 Million) represents 0% of total liabilities (₩9.72 Billion). Also explore 109820 net assets growth trend to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GeneMatrix Inc Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for GeneMatrix Inc across 11 annual periods. Check GeneMatrix Inc (109820) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for GeneMatrix Inc (2014–2024)
Year-by-year free cash flow to debt coverage for GeneMatrix Inc. For the full company profile including market capitalisation, see market value of GeneMatrix Inc.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.02x | ₩-166.46 Million | ₩-200.12 Million | ₩9.23 Billion | ▲ +93.2% |
| 2023 | -0.27x | ₩-2.18 Billion | ₩-2.35 Billion | ₩8.21 Billion | ▼ -141.6% |
| 2022 | -0.11x | ₩-850.50 Million | ₩-1.02 Billion | ₩7.72 Billion | ▼ -121.9% |
| 2021 | 0.50x | ₩3.63 Billion | ₩3.37 Billion | ₩7.21 Billion | ▼ -50.7% |
| 2020 | 1.02x | ₩4.87 Billion | ₩4.51 Billion | ₩4.78 Billion | ▲ +745.8% |
| 2019 | -0.16x | ₩-2.09 Billion | ₩-2.28 Billion | ₩13.21 Billion | ▼ -36.5% |
| 2018 | -0.12x | ₩-2.39 Billion | ₩-2.74 Billion | ₩20.68 Billion | ▲ +51.4% |
| 2017 | -0.24x | ₩-1.59 Billion | ₩-1.77 Billion | ₩6.68 Billion | ▼ -1494.9% |
| 2016 | -0.01x | ₩-102.30 Million | ₩-373.25 Million | ₩6.85 Billion | ▲ +68.7% |
| 2015 | -0.05x | ₩-513.06 Million | ₩-591.96 Million | ₩10.74 Billion | ▲ +77.8% |
| 2014 | -0.22x | ₩-1.11 Billion | ₩-1.38 Billion | ₩5.16 Billion | — |